Palvella Therapeutics Inc (PVLA)
R&D Expense Growth
33.63%
Quarterly · Period ending:
PVLA R&D Expense Growth
Latest reported33.63%period ending
Latest reported33.63%period ending
PVLA Quarterly R&D Growth (QoQ) (0.00% → 33.63%)
Latest values, visible window
High-resolution chart · PNG
PVLA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 33.6297% | |
| 31.0771% | |
| 9.0839% | |
| 27.5498% | |
| 25.6259% | |
| 60.2045% | |
| -20.4318% | |
| 121.6366% | |
| 46.5447% | |
| -77.9075% | |
| -53.58% | |
| -29.2926% | |
| 5.8585% | |
| 0% |